Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:
Schedule
Product: Levothyroxine
Active Ingredient: Levothyroxine sodium 0.1mg
Dosage Form: Tablet
New Zealand Sponsor: Boucher & Muir (NZ) Limited t/a Mercury Pharma (NZ)
Manufacturer: Custom Pharmaceuticals Limited (UK), Sussex, United Kingdom
Note: This renewed consent is valid for two years from 11 November 2012.
Product: Levothyroxine
Active Ingredient: Levothyroxine sodium 0.05mg
Dosage Form: Tablet
New Zealand Sponsor: Boucher & Muir (NZ) Limited t/a Mercury Pharma (NZ)
Manufacturer: Custom Pharmaceuticals Limited (UK), Sussex, United Kingdom
Note: This renewed consent is valid for two years from 11 November 2012.
Dated this 10th day of October 2012.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).